Safety monitoring with ocular anti-vascular endothelial growth factor therapies

Br J Ophthalmol. 2008 Dec;92(12):1573-4. doi: 10.1136/bjo.2008.137604.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aptamers, Nucleotide / adverse effects
  • Diabetic Retinopathy / drug therapy*
  • Humans
  • Macular Degeneration / drug therapy*
  • Macular Edema / drug therapy*
  • Vascular Endothelial Growth Factors / antagonists & inhibitors*

Substances

  • Aptamers, Nucleotide
  • Vascular Endothelial Growth Factors
  • pegaptanib